Cargando…

Racial differences in primary cytogenetic abnormalities in multiple myeloma: a multi-center study

Mostrar otras versiones (1)

Detalles Bibliográficos
Autores principales:	Greenberg, A J, Philip, S, Paner, A, Velinova, S, Badros, A, Catchatourian, R, Ketterling, R, Kyle, R A, Kumar, S, Vachon, C M, Rajkumar, S V
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2015
Materias:	Erratum
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4349262/ https://www.ncbi.nlm.nih.gov/pubmed/25679291 http://dx.doi.org/10.1038/bcj.2015.8

Ejemplares similares

Racial differences in primary cytogenetic abnormalities in multiple myeloma: a multi-center study
por: Greenberg, A J, et al.
Publicado: (2015)

Prognostic implications of abnormalities of chromosome 13 and the presence of multiple cytogenetic high-risk abnormalities in newly diagnosed multiple myeloma
por: Binder, M, et al.
Publicado: (2017)

Cytogenetic abnormalities in multiple myeloma: association with disease characteristics and treatment response
por: Abdallah, Nadine, et al.
Publicado: (2020)

Chronic myelomonocytic leukemia in younger patients: molecular and cytogenetic predictors of survival and treatment outcome
por: Patnaik, M M, et al.
Publicado: (2015)

Occurrence and prognostic significance of cytogenetic evolution in patients with multiple myeloma
por: Binder, M, et al.
Publicado: (2016)

Cytogenetic Abnormalities in Multiple Myeloma Patients at a Tertiary Healthcare Center in India
por: Govindasamy, Perumal, et al.
Publicado: (2019)

Interpretation of cytogenetic results in multiple myeloma for clinical practice
por: Rajan, A M, et al.
Publicado: (2015)

Relationship between initial clinical presentation and the molecular cytogenetic classification of myeloma
por: Greenberg, Alexandra J., et al.
Publicado: (2013)

Erratum to: Racial Disparities in Acromegaly and Cushing’s Disease: A Referral Center Study in 241 Patients
Publicado: (2022)

Cytogenetic abnormality in patients with multiple myeloma analyzed by fluorescent in situ hybridization
por: Hu, Ying, et al.
Publicado: (2016)

Cytogenetic abnormalities in Langerhans cell histiocytosis.
por: Betts, D. R., et al.
Publicado: (1998)

A pooled analysis of outcomes according to cytogenetic abnormalities in patients receiving ixazomib- vs placebo-based therapy for multiple myeloma
por: Chng, Wee-Joo, et al.
Publicado: (2023)

Cytogenetic abnormalities in essential thrombocythemia: Clinical and molecular correlates and prognostic relevance in 809 informative cases
por: Gangat, Naseema, et al.
Publicado: (2022)

Age and cytogenetic abnormalities()
por: Souza, Cármino Antonio de
Publicado: (2018)

Erratum to: Interim analysis of survival in a prospective, multi-center registry cohort of cutaneous melanoma tested with a prognostic 31-gene expression profile test
por: Hsueh, Eddy C., et al.
Publicado: (2017)

Prognostic Impact of Cytogenetic Abnormalities in Multiple Myeloma: A Retrospective Analysis of 229 Patients
por: Jian, Yuan, et al.
Publicado: (2016)

Cytogenetic abnormalities correlate with clinico-biological characteristics in 30 Moroccan multiple myeloma patients
por: Hamdaoui, Hasna, et al.
Publicado: (2023)

P26 LANDSCAPE OF RECURRENT CYTOGENETIC ABNORMALITIES IN PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA AS DETECTED BY CHROMOSOME MICROARRAY ANALYSIS (CMA)
por: Varshavsky Yanovsky, A., et al.
Publicado: (2023)

Aggressive Clinicopathological Course of Myeloma with t(3;16) (q21;q22) Cytogenetic Abnormality
por: Bozkurt, Süreyya, et al.
Publicado: (2019)

Cytogenetic Abnormalities in Multiple Myeloma: Incidence, Prognostic Significance, and Geographic Heterogeneity in Indian and Western Populations
por: Kadam Amare, Pratibha, et al.
Publicado: (2023)

Cytogenetic and molecular abnormalities in chronic myelomonocytic leukemia
por: Patnaik, M M, et al.
Publicado: (2016)

The Role of Immunotherapy in Multiple Myeloma
por: Kocoglu, Mehmet, et al.
Publicado: (2016)

Molecular diagnosis of cytogenetic abnormalities in patients with schizophrenia
por: Bar Shai, M., et al.
Publicado: (2022)

Erratum to: CONCEPTT: Continuous Glucose Monitoring in Women with Type 1 Diabetes in Pregnancy Trial: A multi-center, multi-national, randomized controlled trial - Study protocol
por: Feig, Denice S., et al.
Publicado: (2016)

Dissecting racial disparities in multiple myeloma
por: Marinac, Catherine R., et al.
Publicado: (2020)

Erratum to: Equality in Obstetrical Care: Racial/Ethnic Variation in Group B Streptococcus Screening
por: Bryant, Allison S., et al.
Publicado: (2010)

Waldenstrom macroglobulinemia: prognosis and management
por: Oza, A, et al.
Publicado: (2016)

Bradbury CA, Craig Z, Cook G, et al. Thrombosis in patients with myeloma treated in the Myeloma IX and Myeloma XI phase 3 randomized controlled trials. Blood. 2020;136(9):1091-1104.
Publicado: (2020)

P1279: OUTCOMES OF AUTOLOGOUS STEM CELL TRANSPLANT IN PATIENTS WITH MULTIPLE MYELOMA WITH TWO OR MORE HIGH-RISK CYTOGENETIC ABNORMALITIES
por: Pasvolsky, Oren, et al.
Publicado: (2023)

Rare Cytogenetic Abnormalities in Myelodysplastic Syndromes
por: Bacher, Ulrike, et al.
Publicado: (2015)

Cytogenetic Abnormalities in Myelodysplastic Syndromes: An Overview
por: Zahid, Mohammad Faizan, et al.
Publicado: (2017)

PB2081: CYTOGENETICS OF MULTIPLE MYELOMA IN MOROCCO
por: Moutmir, Yasmine, et al.
Publicado: (2023)

Erratum to: Hypophosphatemic osteomalacia: an unusual clinical presentation of multiple myeloma
por: Reyskens, M., et al.
Publicado: (2015)

Lenalidomide or bortezomib as maintenance treatment remedy the inferior impact of high-risk cytogenetic abnormalities in non-transplant patients with newly diagnosed multiple myeloma: a real-world multi-centered study in China
por: Zhuang, Zhe, et al.
Publicado: (2023)

Carfilzomib in multiple myeloma patients with renal impairment: pharmacokinetics and safety
por: Badros, A Z, et al.
Publicado: (2013)

Erratum: Insights into the pan-microbiome: skin microbial communities of Chinese individuals differ from other racial groups
por: Leung, Marcus H. Y., et al.
Publicado: (2016)

Behavioral profiling of autism connectivity abnormalities – Erratum
por: Snyder, William, et al.
Publicado: (2020)

Erratum to: The Centers for Disease Control and Prevention’s (CDC) Youth Violence Prevention Centers: Paving the Way to Prevention
por: Mercy, James A., et al.
Publicado: (2016)

Risk of Early Mortality in Patients With Newly Diagnosed Multiple Myeloma: Erratum
Publicado: (2016)

Erratum to: A randomized double-blind multi-center trial of hydrogen water for Parkinson’s disease: protocol and baseline characteristics
por: Yoritaka, Asako, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_mgrmbpfr368o4o320156amoto6